CKD impairs barrier function and alters microbial flora of the intestine
- 1 November 2012
- journal article
- dialysis and-transplantation
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 21 (6), 587-592
- https://doi.org/10.1097/mnh.0b013e328358c8d5
Abstract
Chronic kidney disease (CKD) is associated with oxidative stress and inflammation which contribute to progression of kidney disease and its numerous complications. Until recently, little attention had been paid to the role of the intestine and its microbial flora in the pathogenesis of CKD-associated inflammation. This article is intended to provide an over view of the impact of uremia on the structure and function of the gut and its microbial flora and their potential link to the associated systemic inflammation. Recent studies conducted in the author's laboratories have demonstrated marked disintegration of the colonic epithelial barrier structure and significant alteration of the colonic bacterial flora in humans and animals with advanced CKD. The observed disruption of the intestinal epithelial barrier complex can play an important part in the development of systemic inflammation by enabling influx of endotoxin and other noxious luminal contents into the systemic circulation. Similarly via disruption of the normal symbiotic relationship and production, absorption and retention of noxious products, alteration of the microbial flora can contribute to systemic inflammation and uremic toxicity. In fact recent studies have documented the role of colonic bacteria as the primary source of several well known pro-inflammatory/pro-oxidant uremic toxins as well as many as-yet unidentified retained compounds. CKD results in disruption of the intestinal barrier structure and marked alteration of its microbial flora - events that play a major role in the pathogenesis of inflammation and uremic toxicity.Keywords
This publication has 34 references indexed in Scilit:
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseKidney International, 2013
- Colonic Contribution to Uremic SolutesJournal of the American Society of Nephrology, 2011
- Intestinal-Renal Syndrome: Mirage or Reality?Blood Purification, 2011
- Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failureAmerican Journal of Physiology-Renal Physiology, 2010
- Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2009
- Endotoxemia is Related to Systemic Inflammation and Atherosclerosis in Peritoneal Dialysis PatientsClinical Journal of the American Society of Nephrology, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences of the United States of America, 2007
- Mechanisms underlying the resistance to diet-induced obesity in germ-free miceProceedings of the National Academy of Sciences of the United States of America, 2007
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- The gastrointestinal tract in uremiaDigestive Diseases and Sciences, 1993